Lv1
20 积分 2023-01-29 加入
An overview of the preclinical discovery and development of tezepelumab for the treatment of asthma
2天前
已完结
Population Pharmacokinetic Modeling and Exposure–Efficacy and Body Weight–Response Analyses for Tezepelumab in Patients With Severe, Uncontrolled Asthma
2天前
已完结
Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn’s Disease and Ulcerative Colitis
3天前
已完结
Reply to “Chat GPT and the Challenges to Detect Potential Drug–Drug Interactions Related to QT Prolongation”
4天前
已完结
The Unrealized Potential of Advanced Modeling Methods to Inform Early Strategic Planning for Payer Reimbursement
4天前
已完结
Estimation of time to progression and post progression survival using joint modeling of summary level OS and PFS data with an ordinary differential equation model
6天前
已完结
Evaluation of Pharmacokinetics of Lebrikizumab in Healthy Individuals After Subcutaneous Administration Using a Prefilled Syringe or Autoinjector in a Phase 1 Randomized Study
7天前
已完结
Human Dose and Pharmacokinetic Predictions for Biologics at Boehringer Ingelheim: A Retrospective Analysis
23天前
已完结
Population Pharmacokinetic Analysis of Drug–Drug Interactions Between Perampanel and Carbamazepine Using Enzyme Induction Model in Epileptic Patients
24天前
已完结
Prediction of human serum concentration–time profiles of therapeutic monoclonal antibodies using common marmosets ( Callithrix jacchus ): initial assessment with canakinumab, adalimumab, and bevacizumab
28天前
已完结
皖公网安备34019202002308
